4 min listen
Recently Approved Drugs: Nivolumab for Metastatic Colorectal Cancer
FromASCO Education
ratings:
Length:
8 minutes
Released:
Nov 22, 2017
Format:
Podcast episode
Description
Dr. Matthew Yurgelun, assistant professor of medicine at Harvard Medical School and gastrointestinal medical oncologist at the Dana Farber Gastrointestinal Cancer Center and Cancer Genetics and Prevention Program, presents information on the recently approved nivolumab for the treatment of patients 12 years and older with mismatch repair deficient and microsatellite instability high metastatic colorectal cancer.
Released:
Nov 22, 2017
Format:
Podcast episode
Titles in the series (100)
Self-Evaluation: Metastatic Breast Cancer: Self-Evaluation: Metastatic Breast Cancer by ASCO Education